INOVIO PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent
INOVIO PHARMACEUTICALS, INC. (INO) had Operating Lease, Liability, Noncurrent of $5.10 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Noncurrent $5.10M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $5.79M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $6.55M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $7.28M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $5.10M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $5.79M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.55M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.28M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $8.00M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $8.70M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $9.37M 10-K · filed 2026-03-12 |
| 2024-09-30 | $10.02M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $10.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.27M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $11.03M 10-K · filed 2025-03-18 |
| 2023-09-30 | $11.19M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.19M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $12.66M 10-K · filed 2024-03-06 |
| 2022-09-30 | $13.31M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $14.05M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.77M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $15.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | $16.13M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $16.80M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $17.44M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $18.06M 10-K · filed 2022-03-01 |
| 2020-09-30 | $18.67M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $19.26M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $19.83M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $20.41M 10-K · filed 2021-03-01 |
| 2019-09-30 | $20.95M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $21.48M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $21.99M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $22.48M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |